The Trustee of the ATS Liquidating Trust (Pink Sheets:ATISZ -- please read the disclaimer in the last paragraph of this release regarding trading under this symbol) today announced he has entered into an agreement to sell the Trust's Anginera(TM) intellectual property to Iken Tissue Therapeutics, Inc. of San Francisco. Anginera is a human fibroblast-based, tissue-engineered, epicardial patch.
